We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+3.26%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.77%
5 Year Est. Return
+48.6%
10 Year Est. Return
–
AUM
$257M
AUM Growth
+$11.7M
Cap. Flow
+$5.42M
Cap. Flow %
2.11%
Top 10 Hldgs %
38.42%
Holding
78
New
1
Increased
26
Reduced
18
Closed
–

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.36M
2
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
+$1.13M
3
AAPL icon
Apple
AAPL
+$930K
4
KMPR icon
Kemper
KMPR
+$777K
5
AGN
Allergan plc
AGN
+$679K

Top Sells

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$882K
2
VZ icon
Verizon
VZ
+$77.8K
3
HD icon
Home Depot
HD
+$66.1K
4
SPXC icon
SPX Corp
SPXC
+$64.1K
5
DO
Diamond Offshore Drilling
DO
+$63.3K

Sector Composition

Rank Sector Weight
1 Healthcare 27.82%
2 Industrials 21.56%
3 Technology 14.53%
4 Energy 12.91%
5 Consumer Staples 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCAR icon
1
PACCAR
PCAR
$69.6B
$14.7M 5.71%
424,457
– –
WBA
2
DELISTED
Walgreens Boots Alliance
WBA
$13.7M 5.33%
164,632
+6,256
+4% +$505K
HD icon
3
Home Depot
HD
$332B
$9.66M 3.76%
75,628
-500
-0.7% -$66.1K
JNJ icon
4
Johnson & Johnson
JNJ
$635B
$9.28M 3.61%
76,529
-186
-0.2% -$21.1K
COST icon
5
Costco
COST
$415B
$9.22M 3.59%
58,707
– –
HUBB icon
6
Hubbell
HUBB
$25.7B
$9.2M 3.58%
87,246
– –
INTC icon
7
Intel
INTC
$466B
$8.89M 3.46%
271,071
-630
-0.2% -$19.7K
BIIB icon
8
Biogen
BIIB
$29.9B
$8.46M 3.29%
34,963
+5,172
+17% +$1.36M
WWD icon
9
Woodward
WWD
$25B
$7.93M 3.09%
137,607
-240
-0.2% -$13.3K
AAPL icon
10
Apple
AAPL
$4.89T
$7.7M 3%
322,352
+37,416
+13% +$930K
XOM icon
11
ExxonMobil
XOM
$651B
$6.58M 2.56%
70,217
– –
IBM icon
12
IBM
IBM
$202B
$6.36M 2.47%
43,822
+2,020
+5% +$289K
PEP icon
13
PepsiCo
PEP
$186B
$6.22M 2.42%
58,730
– –
SLB icon
14
SLB Ltd
SLB
$77.8B
$6.17M 2.4%
78,064
+15
+0% +$1.15K
WAT icon
15
Waters Corp
WAT
$36.8B
$6.01M 2.34%
42,732
– –
EQT icon
16
EQT Corp
EQT
$33.2B
$5.9M 2.29%
139,908
– –
ABBV icon
17
AbbVie
ABBV
$458B
$5.06M 1.97%
81,783
+9,543
+13% +$581K
NVS icon
18
Novartis
NVS
$295B
$4.92M 1.91%
66,509
– –
MSFT icon
19
Microsoft
MSFT
$2.84T
$4.83M 1.88%
94,364
+2,045
+2% +$106K
CL icon
20
Colgate-Palmolive
CL
$72.6B
$4.55M 1.77%
62,221
– –
DE icon
21
Deere & Co
DE
$170B
$4.4M 1.71%
54,332
+446
+0.8% +$36.6K
MDT icon
22
Medtronic
MDT
$107B
$4.4M 1.71%
50,693
+665
+1% +$53.8K
FLS icon
23
Flowserve
FLS
$9.25B
$4.29M 1.67%
95,031
+673
+0.7% +$31.5K
AEGN
24
DELISTED
Aegion Corp
AEGN
$4.04M 1.57%
207,288
+2,994
+1% +$59.9K
EMR icon
25
Emerson Electric
EMR
$82.9B
$3.99M 1.55%
76,469
+765
+1% +$40.6K
1
2 3 4

Similar funds

CFS
Ceros Financial Services Rockville, Maryland $316M AUM
SVWA
Sound View Wealth Advisors Savannah, Georgia $319M AUM
SAS
Sarbit Advisory Services Winnipeg, Manitoba, Canada $294M AUM 0.68% 1-Year Est. Return
LYV
Live Your Vision West Conshohocken, Pennsylvania $330M AUM 2.28% 1-Year Est. Return
TAT
TD Ameritrade Trust Denver, Colorado $285M AUM 0.17% 1-Year Est. Return
NAP
New Amsterdam Partners New York $272M AUM 12.21% 1-Year Est. Return
OAMU
Ostrum Asset Management US New York $359M AUM
TCM
Tradition Capital Management Summit, New Jersey $369M AUM 6.72% 1-Year Est. Return

Thompson Rubinstein Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Thompson Rubinstein Investment Management held 78 positions worth $257M, up 4.8% from $245M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 1.3%. Thompson Rubinstein Investment Management opened 1 new position and made no exits, leaving the 78-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Technology.

  • Thompson Rubinstein Investment Management's largest Q2 2016 buy was Allergan plc: 2,946 shares worth $681K.
  • Thompson Rubinstein Investment Management added most to Biogen in Q2 2016, an estimated $1.36M increase.
  • Thompson Rubinstein Investment Management's biggest Q2 2016 reduction was Devon Energy, cutting an estimated $882K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 38% of its $257M portfolio in Q2 2016.
  • Thompson Rubinstein Investment Management opened 1 new position and closed 0 in Q2 2016.
  • Thompson Rubinstein Investment Management's portfolio value rose 4.8% quarter-over-quarter to $257M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q2 2016, filed 8 Jul 2016.